Stoke Therapeutics, Inc. (NASDAQ:STOK) is held by 178 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 31 Mar, 2026 | 5,623,525 | 76,669 | 1.38% | $183,101,974.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 5,385,714 | 173,160 | 3.32% | $175,358,848.00 |
| FMR LLC | 31 Mar, 2026 | 5,383,666 | -217,254 | -3.88% | $175,292,165.00 |
| Lynx1 Capital Management LP | 31 Mar, 2026 | 4,763,673 | -641,001 | -11.86% | $155,105,193.00 |
| Redmile Group, LLC | 31 Mar, 2026 | 4,164,120 | 130,050 | 3.22% | $135,583,747.00 |
| Morgan Stanley | 31 Mar, 2026 | 3,423,280 | -122,878 | -3.47% | $111,461,996.00 |
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 3,336,697 | 0 | 0.00% | $108,642,854.00 |
| Toronto Dominion Bank | 31 Mar, 2026 | 3,173,258 | 0 | 0.00% | $103,321,280.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Mar, 2026 | 3,095,700 | 2,359,901 | 320.73% | $100,795,992.00 |
| BVF INC/IL | 31 Mar, 2026 | 2,547,557 | 281,883 | 12.44% | $82,948,456.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 2,355,603 | 2,355,603 | 0.00% | $76,698,434.00 |
| State Street Corp | 31 Mar, 2026 | 2,276,512 | -221,537 | -8.87% | $74,123,231.00 |
| Siren, L.L.C. | 31 Mar, 2026 | 1,995,347 | -252,000 | -11.21% | $64,968,498.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 31 Mar, 2026 | 1,934,171 | 1,934,171 | 0.00% | $62,977.00 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 31 Mar, 2026 | 1,823,500 | 0 | 0.00% | $59,373,160.00 |
| Janus Henderson Group Plc | 31 Mar, 2026 | 1,631,681 | 180,748 | 12.46% | $53,070,426.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 1,322,260 | 156,115 | 13.39% | $43,060,709.00 |
| Polar Capital Holdings Plc | 31 Mar, 2026 | 1,132,511 | -136,620 | -10.76% | $36,874,558.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 989,936 | 162,797 | 19.68% | $32,228,581.00 |
| Assenagon Asset Management S.A. | 31 Mar, 2026 | 907,015 | -320,708 | -26.12% | $29,532,408.00 |